News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Article

Pharmaceutical Executive

January 31, 2006

Pharmaceutical Executive

Pharmaceutical Executive-01-31-2006
Volume0
Issue 0

Popular Web Site Used to Predict Epidemic Patterns

An entertaining Internet program that allows Americans to see where a dollar goes after they spend it, helped scientists develop a formula for how infectious diseases spread geographically in United States.

Inspiration comes from the most unexpected places. An international team of scientists discovered a mathematical law that can be used to predict the spread of an infectious disease across the country. The key to their discovery? Wheresgeorge.com, a recreational Web site that allows people to track dollar bills by serial number.

    One of the researchers, Lars Hufnagel, a post-doctoral fellow at the Kavli Institute for Theoretical Physics at the University of California, Santa Barbara, said the team was looking for a way to understand how diseases spread geographically inside a country. Airline travel routes can be used to predict international infection patterns, he explained, but domestic travel takes too many forms to successfully use any one as an indicator.

    They were looking for something quantifiable that traveled the way diseases travel but was not specific to any illness, he said. The wheresgeorge data were such a good match because currency, like disease, is almost always attached to humans when it travels.

    Human travel has no scale, Hufnagel said, because people frequently travel short distances, sometimes travel moderate distances, and occasionally travel long distances. But the team found that human travel in the United States could be described by a mathematical formula known as a scaling law.

    Scaling laws, which look a little like logarithmic functions to the unsophisticated, are used to determine proportionality. The laws give a sense of perspective to observers, allowing them to understand variables. A simple example of scaling: Geologists often put a hammer next to a rock when they photograph it for their records. By using a hammer of constant size, the scientists can use a formula to compare the size of rocks in two different photographs.

    It turns out that a simple scaling law can describe the way humans travel and predict how a disease spreads.

    “The scaling law is always the same -- from a few miles up to across the country,” Hufnagel said about the formula that describes human travel. “It doesn’t depend on where in the United States you are.”

    The next step, according to Hufnagel, is to couple this information about how disease spreads geographically with local infection data that demonstrate how infections spread from person to person. Such data show how many people one sick person infects.

    Together these data can be used to create a model, which the team plans to test by simulating past disease epidemics and comparing their predictions to the actual event.

    Although the statistical laws discovered by the wheresgeorge study are specific to the United States, Hufnagel believes the findings will translate to other developed nations with sophisticated transportation systems.

“I would be very surprised if it is different,” he said

Articles in this issue

PED_article_logo-301532-1408683917411.gif
Popular Web Site Used to Predict Epidemic Patterns
PED_article_logo-301530-1408683919870.gif
ImClone Searches for Potential Buyer

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Michael Grosberg
Related Content
Advertisement
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
August 27th 2025

Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 27th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 27th 2025

Genentech Breaks Ground for New Manufacturing Facility in North Carolina

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 27th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 27th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder
August 27th 2025

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder

Don Tracy, Associate Editor
Related Content
Advertisement
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
August 27th 2025

Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 27th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 27th 2025

Genentech Breaks Ground for New Manufacturing Facility in North Carolina

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 27th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 27th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder
August 27th 2025

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder

Don Tracy, Associate Editor
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.